307 related articles for article (PubMed ID: 20192728)
1. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
[TBL] [Abstract][Full Text] [Related]
2. Adolescent with neuropsychiatric symptoms associated with novel influenza A (H1N1) virus infection.
German-Diaz M; Pavo-Garcia R; Diaz-Diaz J; Giangaspro-Corradi E; Negreira-Cepeda S
Pediatr Infect Dis J; 2010 Jun; 29(6):570-1. PubMed ID: 20173676
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
4. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
[TBL] [Abstract][Full Text] [Related]
5. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
Greener M
Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
[No Abstract] [Full Text] [Related]
6. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
7. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
8. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
[TBL] [Abstract][Full Text] [Related]
9. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
10. Hematemesis in a 2009 H1N1 influenza patient.
Adalja AA
Am J Emerg Med; 2010 Sep; 28(7):846.e3-4. PubMed ID: 20837276
[No Abstract] [Full Text] [Related]
11. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
[No Abstract] [Full Text] [Related]
12. Pericardial effusion complicating novel influenza A (H1N1) infection in an infant.
Koranyi K; Yontz D; Rohrer Z; Leber A; Ramilo O
Pediatr Infect Dis J; 2010 Aug; 29(8):782-3. PubMed ID: 20661108
[TBL] [Abstract][Full Text] [Related]
13. Influenza A H1N1 and severe asthma exacerbation.
Sposato B; Croci L; Canneti E; Di Tomassi M; Migliorini MG; Ricci A; Mariotta S; Toti M
Eur Rev Med Pharmacol Sci; 2010 May; 14(5):487-90. PubMed ID: 20556930
[TBL] [Abstract][Full Text] [Related]
14. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
15. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
[TBL] [Abstract][Full Text] [Related]
16. [Neuraminidase inhibitors and high risk of influenza complications: considered and widely-supported recommendations].
van Dissel JT; Coutinho RA; van der Sande MA
Ned Tijdschr Geneeskd; 2009; 153():B486. PubMed ID: 20051160
[TBL] [Abstract][Full Text] [Related]
17. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
Kumar A
J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
[TBL] [Abstract][Full Text] [Related]
18. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(18):497-500. PubMed ID: 19444154
[TBL] [Abstract][Full Text] [Related]
19. Severe novel H1N1 influenza A infection in the immediate postoperative period of a liver transplant patient.
Zapata R; Uribe M; Martínez W; Andrade A; Leal JL; Gomez F
Liver Transpl; 2010 Apr; 16(4):447-52. PubMed ID: 20205234
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
